COPENHAGEN (Reuters) - Denmark's Novo Nordisk, the world's biggest insulin producer, said Phase III study results had shown people treated with its liraglutide drug had an 8 percent weight loss. "These data, together with previously reported Phase III trials, consistently demonstrate clinically significant weight loss and??
Source: http://rss.news.yahoo.com/rss/weightloss
miguel cabrera Karrueche Tran dodd frank Lark Voorhies Jennifer Livingston Orlando Cruz MLB Playoff Schedule
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.